Mar Bosch-Queralt

Dr. Mar Bosch-Queralt

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
GGGaryfallia Gouna
Garyfallia Gouna
CKChristian Klose
Christian Klose
MBMar Bosch-Queralt
Mar Bosch-Queralt
LLLu Liu
Lu Liu
OGOzgun Gokce
Ozgun Gokce
MSMikael Simons
Mikael Simons
Upon demyelinating injury, microglia orchestrate a regenerative response that promotes myelin repair, thereby restoring rapid signal propagation and protecting axons from further damage. Whereas the essential phagocytic function of microglia for remyelination is well known, the underlying metabolic pathways required for myelin debris clearance are poorly understood. Here, we show that cholesterol esterification in male mouse microglia/macrophages is a necessary adaptive response to myelin debris uptake and required for the generation of lipid droplets upon demyelinating injury. When lipid droplet biogenesis is defective, innate immune cells do not resolve, and the regenerative response fails. We found that triggering receptor expressed on myeloid cells 2 (TREM2)–deficient mice are unable to adapt to excess cholesterol exposure, form fewer lipid droplets, and build up endoplasmic reticulum (ER) stress. Alleviating ER stress in TREM2-deficient mice restores lipid droplet biogenesis and resolves the innate immune response. Thus, we conclude that TREM2-dependent formation of lipid droplets constitute a protective response required for remyelination to occur.

18 February 2021 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
MBMar Bosch-Queralt
Mar Bosch-Queralt
LCLudovico Cantuti-Castelvetri
Ludovico Cantuti-Castelvetri
ADAlkmini Damkou
Alkmini Damkou
MSMartina Schifferer
Martina Schifferer
KSKai Schlepckow
Kai Schlepckow
MSMikael Simons
Mikael Simons

26 October 2021 in Cell Reports
Verified
Journal Article
Open access
HPHorst Penkert
Horst Penkert
ABAlix Bertrand
Alix Bertrand
VTVini Tiwari
Vini Tiwari
SBStephan Breimann
Stephan Breimann
SMStephan A. Müller
Stephan A. Müller
MSMikael Simons
Mikael Simons
After demyelinating injury of the central nervous system, resolution of the mounting acute inflammation is crucial for the initiation of a regenerative response. Here, we aim to identify fatty acids and lipid mediators that govern the balance of inflammatory reactions within demyelinating lesions. Using lipidomics, we identify bioactive lipids in the resolution phase of inflammation with markedly elevated levels of n-3 polyunsaturated fatty acids. Using fat-1 transgenic mice, which convert n-6 fatty acids to n-3 fatty acids, we find that reduction of the n-6/n-3 ratio decreases the phagocytic infiltrate. In addition, we observe accelerated decline of microglia/macrophages and enhanced generation of oligodendrocytes in aged mice when n-3 fatty acids are shuttled to the brain. Thus, n-3 fatty acids enhance lesion recovery and may, therefore, provide the basis for pro-regenerative medicines of demyelinating diseases in the central nervous system.

29 January 2022 in STAR Protocols
Verified
Journal Article
Open access
MBMar Bosch-Queralt
Mar Bosch-Queralt
VTVini Tiwari
Vini Tiwari
ADAlkmini Damkou
Alkmini Damkou
LVLenka Vaculčiaková
Lenka Vaculčiaková
IAIoannis Alexopoulos
Ioannis Alexopoulos
MSMikael Simons
Mikael Simons
Lysolecithin injections into the white matter tracts of the central nervous system are a valuable tool to study remyelination, but evaluating the resulting demyelinating lesion size is challenging. Here, we present a protocol to consistently measure the volume of demyelination and remyelination in mice following brain lysolecithin injections. We describe serial sectioning of the lesion, followed by the evaluation of the demyelinated area in two-dimensional images. We then detail the computation of the volume using our own automated iPython script.

23 February 2023 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
MBMar Bosch-Queralt
Mar Bosch-Queralt
LCLudovico Cantuti-Castelvetri
Ludovico Cantuti-Castelvetri
ADAlkmini Damkou
Alkmini Damkou
MSMartina Schifferer
Martina Schifferer
KSKai Schlepckow
Kai Schlepckow
MSMikael Simons
Mikael Simons

4 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SSSara Salvany
Sara Salvany
SHSara Hernández
Sara Hernández
ACAnna Garcia Casanovas
Anna Garcia Casanovas
SGSílvia Gras
Sílvia Gras
LPLídia Piedrafita
Lídia Piedrafita
OTOlga Tarabal
Olga Tarabal
Neuregulins (NRGs) are ligands for tyrosine kinase receptors from the ErbB family and serve multiple developmental functions in the nervous system. NRG1-ErbB signaling regulates myelination and is associated with amyotrophic lateral sclerosis (ALS) pathology. Given the potential therapeutic relevance of this pathway for motor neuron (MN) diseases, we employed a transgenic (TG) mouse model with persistent neuronal overexpression of NRG type III (NRG1-III) to investigate its long-term impact on the neuromuscular system. We examined MNs and their synaptic inputs, including cholinergic C-boutons, at which NRG1-III typically accumulates. MNs from TG mice exhibited persistent upregulation of C-bouton-associated postsynaptic proteins, as well as increased biogenesis of subsynaptic cistern-like ER-plasma membrane contacts. Following nerve injury, NRG1-III overexpression resulted in exacerbated neuroinflammation and disruption of enlarged NRG1 clusters. Calcium imaging revealed altered homeostasis in TG MNs, which upregulated molecules linked to axonal plasticity. At neuromuscular junctions, we observed regressive changes involving autophagic dysregulation. These alterations were accompanied by increased motor activity in behavioral tests. Overall, our findings indicate that persistently elevated NRG1-III signaling diminishes MN connectivity and long-term health, which must be considered when developing therapeutic strategies for neurodegenerative diseases, such as ALS.